[HTML][HTML] The emergence, genomic diversity and global spread of SARS-CoV-2
Since the first cases of COVID-19 were documented in Wuhan, China in 2019, the world has
witnessed a devastating global pandemic, with more than 238 million cases, nearly 5 million …
witnessed a devastating global pandemic, with more than 238 million cases, nearly 5 million …
Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities
Various next generation sequencing (NGS) based strategies have been successfully used in
the recent past for tracing origins and understanding the evolution of infectious agents …
the recent past for tracing origins and understanding the evolution of infectious agents …
[HTML][HTML] Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
Abstract The Omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) was initially identified in November 2021 in South Africa and Botswana, as …
2 (SARS-CoV-2) was initially identified in November 2021 in South Africa and Botswana, as …
[HTML][HTML] SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity
The causative agent of the COVID-19 pandemic, SARS-CoV-2, is steadily mutating during
continuous transmission among humans. Such mutations can occur in the spike (S) protein …
continuous transmission among humans. Such mutations can occur in the spike (S) protein …
[HTML][HTML] Sixteen novel lineages of SARS-CoV-2 in South Africa
The first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in South
Africa was identified on 5 March 2020, and by 26 March the country was in full lockdown …
Africa was identified on 5 March 2020, and by 26 March the country was in full lockdown …
[HTML][HTML] Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission
A Escalera, AS Gonzalez-Reiche, S Aslam, I Mena… - Cell host & …, 2022 - cell.com
SARS-CoV-2 lineages have diverged into highly prevalent variants termed" variants of
concern"(VOCs). Here, we characterized emerging SARS-CoV-2 spike polymorphisms in …
concern"(VOCs). Here, we characterized emerging SARS-CoV-2 spike polymorphisms in …
[HTML][HTML] SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-
derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …
derived mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
Investment in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing
in Africa over the past year has led to a major increase in the number of sequences that …
in Africa over the past year has led to a major increase in the number of sequences that …
[HTML][HTML] Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection
LG Jacobs, E Gourna Paleoudis, D Lesky-Di Bari… - PloS one, 2020 - journals.plos.org
Background Characterizing the prevalence and persistence of symptoms associated with
COVID-19 infection following hospitalization and their impact is essential to planning post …
COVID-19 infection following hospitalization and their impact is essential to planning post …
[HTML][HTML] COVID-19 outbreak—New York City, February 29–June 1, 2020
CN Thompson - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Approximately 203,000 cases of laboratory-confirmed COVID-19 were reported in NYC
during the first 3 months of the pandemic. The crude fatality rate among confirmed cases …
during the first 3 months of the pandemic. The crude fatality rate among confirmed cases …